Global Pharmaceutical-grade Periodic Acid Market was valued at USD 139 million in 2025. The market is projected to grow from USD 148 million in 2026 to USD 211 million by 2034, exhibiting a CAGR of 6.1% during the forecast period. In terms of volume, sales reached 2,407 tons in 2025, with an average price of USD 63.24 per kilogram.
Pharmaceutical-grade periodic acid is defined as a high-purity oxidizing agent that meets stringent pharmacopoeial standards such as USP, EP, or BP, or is certified as a GMP excipient. It is primarily used in critical applications including disinfection, sterilization, glycoprotein Periodic Acid-Schiff (PAS) staining, and active pharmaceutical ingredient (API) synthesis. The most common form is orthoperiodic acid (H5IO6), which must adhere to strict purity specifications, typically requiring a purity level of 99.5% or higher, heavy metal content below 10 ppm, and endotoxin levels not exceeding 0.25 EU·mL-1.
Market growth is underpinned by the expanding pharmaceutical and biotechnology sectors, which demand high-purity reagents for research, diagnostics, and manufacturing. However, the market is sensitive to raw material costs, as iodine constitutes 60-65% of production cost, with its price fluctuating significantly. Key global players, including Ajay-SQM Group, Iofina Chemical, and William Blythe, maintain a significant presence, driving innovation and supply to meet the stringent requirements of the healthcare industry.
Download FREE Sample Report:
https://www.24chemicalresearch.com/download-sample/300285/pharmaceuticalgrade-periodic-acid-market
Market Overview & Regional Analysis
North America, with the U.S. as its dominant market, is a leading region reinforced by its advanced pharmaceutical and biotechnology sectors demanding high-purity excipients and reagents. The region's strict regulatory framework, including adherence to USP standards and strong GMP compliance, ensures product quality and safety, creating a high-barrier, high-value market. Major end-users include leading pharmaceutical companies and diagnostic laboratories that prioritize reliable, endotoxin-controlled materials.
Europe represents a major and mature market characterized by its strong pharmaceutical manufacturing base and harmonized regulatory standards under the European Pharmacopoeia. Germany, France, and the U.K. are significant consumers, utilizing the product in pharmaceutical production and advanced research institutions. The market dynamics are shaped by a focus on quality and compliance with EP and BP specifications, ensuring products meet high safety benchmarks.
Asia, led by China and Japan, is a rapidly growing and highly competitive region. China's expanding pharmaceutical and API manufacturing sector is a key growth driver, with numerous local manufacturers contributing to both supply and demand. Japan's market is characterized by its advanced technology and stringent quality requirements. The region benefits from cost-effective manufacturing capabilities and access to raw materials like iodine.
South America is smaller but developing, with Brazil and Argentina as primary markets. Demand is primarily linked to the local pharmaceutical industry and academic research institutions. Import dependency is common for high-purity grades, influencing market dynamics and pricing.
The Middle East & Africa represents an emerging market with fragmented demand. Focus is primarily on countries with growing pharmaceutical sectors, such as Turkey, Israel, and Saudi Arabia. Demand is generally tied to imports for use in hospital laboratories, limited pharmaceutical manufacturing, and academic research.
Key Market Drivers and Opportunities
The expanding research and development activities in pharmaceutical and life sciences sectors drive demand for this high-purity compound essential for oxidizing complex organic molecules in API synthesis. The market for high-purity laboratory reagents is projected to grow at 6-8% CAGR over the next five years. Increasing stringency of regulatory standards for drug approval mandates rigorous testing protocols, directly increasing consumption.
The rapid growth of the biologics and biosimilars market presents significant opportunity, with characterization of complex biomolecules relying heavily on techniques involving periodic acid for analyzing glycosylation patterns. Increasing pharmaceutical R&D expenditure and new manufacturing facilities in emerging economies across Asia-Pacific and Latin America create substantial growth opportunities. Development of more user-friendly and safer formulations, such as stabilized solutions or single-use vials, can reduce handling risks and improve convenience.
Challenges & Restraints
Compliance with cGMP, USP, and various pharmacopeias requires significant investment in quality assurance, documentation, and facility audits, increasing overall production costs. Handling a strong oxidizing agent poses inherent safety risks, necessitating specialized infrastructure. The significant price premium associated with pharmaceutical-grade material compared to technical or laboratory grades acts as a major restraint. Application of periodic acid is largely confined to specialized synthetic chemistry steps and specific analytical techniques, limiting the total addressable market.
Market Segmentation by Type:
- Orthoperiodic Acid
• Metaperiodic Acid
Market Segmentation by Application:
- Biochemical Diagnostics
• Pharmaceuticals
• Other
Download FREE Sample Report:
https://www.24chemicalresearch.com/download-sample/300285/pharmaceuticalgrade-periodic-acid-market
Market Segmentation and Key Players
The market features a moderately concentrated competitive landscape dominated by a handful of established chemical manufacturers with expertise in iodine chemistry and GMP-compliant production. The top five players collectively held a significant revenue share in 2025. Ajay-SQM Group benefits from backward integration into raw iodine supply, providing a distinct cost advantage.
- Ajay-SQM Group (Chile/India)
• Iofina Chemical (United States/United Kingdom)
• William Blythe (United Kingdom)
• Nippoh Chemicals (Japan)
• Samrat Pharmachem (India)
• Omkar Speciality Chemicals (India)
• Zhejiang Hichi Chemical (China)
• Jiangxi Shengdian S&T (China)
• Prachi Pharmaceuticals (India)
• DNS Fine (India)
• Infinium Pharmachem (India)
• Taian Havay Group (China)
Report Scope
This report presents a comprehensive analysis of the global and regional markets for Pharmaceutical-grade Periodic Acid, covering the period from 2026 to 2034. It includes detailed insights with specific focus on:
- Sales, sales volume, and revenue forecasts
• Detailed segmentation by type and application
In addition, the report offers in-depth profiles of key industry players, including:
- Company profiles
• Product specifications
• Production capacity and sales
• Revenue, pricing, gross margins
• Sales performance
As part of this research, we surveyed Pharmaceutical-grade Periodic Acid companies and industry experts. The survey covered various aspects, including:
- Revenue and demand trends
• Product types and recent developments
• Strategic plans and market drivers
• Industry challenges, obstacles, and potential risks
Get Full Report Here:
https://www.24chemicalresearch.com/reports/300285/pharmaceuticalgrade-periodic-acid-market
About 24chemicalresearch
Founded in 2015, 24chemicalresearch has rapidly established itself as a leader in chemical market intelligence, serving clients including over 30 Fortune 500 companies. We provide data-driven insights through rigorous research methodologies.
- Plant-level capacity tracking
• Real-time price monitoring
• Techno-economic feasibility studies
With a dedicated team of researchers possessing over a decade of experience, we focus on delivering actionable, timely, and high-quality reports.
International: +1(332) 2424 294 | Asia: +91 9169162030
Website: https://www.24chemicalresearch.com/
Follow us on LinkedIn: https://www.linkedin.com/company/24chemicalresearch